1. ANTIMICROBIAL RESISTANCE FOR STAPHYLOCOCCUS AUREUS NASAL STRAINS ISOLATED DURING 2010-2016 IN SUCEAVA, ROMANIA.
- Author
-
R., Filip, F., Filip, and Z., Croitor
- Subjects
- *
STAPHYLOCOCCUS aureus , *DRUG resistance in bacteria , *ANTI-infective agents , *PUBLIC health , *DISC diffusion tests (Microbiology) - Abstract
Aims: To identify the ratio for nasal carriage of Staphylococcus aureus in general population; to report data on resistance pattern of the studied strains. Methods: Between October 2010-August 2016 in the Hipocrat Clinical Laboratory we processed 471 nasal swabs according to standard procedure; we isolated 175 S. aureus strains. Sensitivity testing was done by disk diffusion method against the following agents: Penicillin, Cefoxitin, Erythromycin, Clarithromycin, Azitromycin, Tetracycline, Sulfamethoxazole/Trimethoprim, Gentamicin, Tobramycin, Amikacin, Ciprofloxacin, Levofloxacin, and Ofloxacin. Interpretation was done according to Clinical and Laboratory Standards Institute (CLSI) criteria. Results: Almost all the isolates were Penicillin resistant (98.2%), macrolide resistance was encountered in 59.4% of strains, quinolone resistance in 6.28%, Gentamicin 3.42% while for Sulphametoxazol/Trimetoprim and Tetracycline, resistance ratio was 24.57% and 37.12% respectively. Conclusion: Resistance ratio for Staphylococcus aureus nasal isolates to anti staphylococcal agents is high-with no predictable trend for the next period. The best way to prevent its increase is prudent use of antibiotics and topic application for nasal carriers. Also the health and nutritional status of these patients is very important. [ABSTRACT FROM AUTHOR]
- Published
- 2017